APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Veterinary Pain Management Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oral Veterinary Pain Management Drugs Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchOral Veterinary Pain Management Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Veterinary Pain Management Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Oral Veterinary Pain Management Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Veterinary Pain Management Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Veterinary Pain Management Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Oral Veterinary Pain Management Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Oral Veterinary Pain Management Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oral Veterinary Pain Management Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oral Veterinary Pain Management Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oral Veterinary Pain Management Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Oral Veterinary Pain Management Drugs include Zoetis, Merck & Co, Medtronic, Lilly, Bayer Pharma AG, Baxter, Norbrook Laboratories, Halyard and Forest Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Oral Veterinary Pain Management Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oral Veterinary Pain Management Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Oral Veterinary Pain Management Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Veterinary Pain Management Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Veterinary Pain Management Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Oral Veterinary Pain Management Drugs revenue, projected growth trends, production technology, application and end-user industry.

Oral Veterinary Pain Management Drugs Segment by Company

Zoetis

Merck & Co

Medtronic

Lilly

Bayer Pharma AG

Baxter

Norbrook Laboratories

Halyard

Forest Laboratories

Endo International

Elanco

Ceva Sante Animale

Bostonscientific

Boehringer Ingelheim

Oral Veterinary Pain Management Drugs Segment by Type

Sedatives

Local Anesthetics

Nonsteroidal Anti-Inflammatory Drugs (NSIDs)

Opioids

α2-Adrenergic Agonists

Other

Oral Veterinary Pain Management Drugs Segment by Application

Veterinary Clinics

Veterinary Hospitals

For Retail

Others

Oral Veterinary Pain Management Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Veterinary Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Veterinary Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Veterinary Pain Management Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Oral Veterinary Pain Management Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Oral Veterinary Pain Management Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Veterinary Pain Management Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Veterinary Pain Management Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sedatives Major Player Table 3. Local Anesthetics Major Player Table 4. Nonsteroidal Anti-Inflammatory Drugs (NSIDs) Major Player Table 5. Opioids Major Player Table 6. α2-Adrenergic Agonists Major Player Table 7. Other Major Player Table 8. Global Oral Veterinary Pain Management Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Veterinary Clinics Major Player Table 10. Veterinary Hospitals Major Player Table 11. For Retail Major Player Table 12. Others Major Player Table 13. Oral Veterinary Pain Management Drugs Industry Trends Table 14. Oral Veterinary Pain Management Drugs Industry Drivers Table 15. Oral Veterinary Pain Management Drugs Industry Opportunities and Challenges Table 16. Oral Veterinary Pain Management Drugs Industry Restraints Table 17. Global Oral Veterinary Pain Management Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Oral Veterinary Pain Management Drugs Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Oral Veterinary Pain Management Drugs Market Share by Region (2021-2026) Table 20. Global Oral Veterinary Pain Management Drugs Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Oral Veterinary Pain Management Drugs Market Share by Region (2027-2032) Table 22. Global Oral Veterinary Pain Management Drugs Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Oral Veterinary Pain Management Drugs Revenue Market Share by Players (2021-2026) Table 24. Global Oral Veterinary Pain Management Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Oral Veterinary Pain Management Drugs Key Players Headquarters & Area Served Table 26. Global Oral Veterinary Pain Management Drugs Players, Product Type & Application Table 27. Global Oral Veterinary Pain Management Drugs Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Oral Veterinary Pain Management Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Oral Veterinary Pain Management Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Oral Veterinary Pain Management Drugs Revenue Market Share by Type (2021-2026) Table 34. Global Oral Veterinary Pain Management Drugs Revenue Market Share by Type (2027-2032) Table 35. Global Oral Veterinary Pain Management Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Oral Veterinary Pain Management Drugs Revenue Market Share by Application (2021-2026) Table 39. Global Oral Veterinary Pain Management Drugs Revenue Market Share by Application (2027-2032) Table 40. Zoetis Company Information Table 41. Zoetis Business Overview Table 42. Zoetis Oral Veterinary Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Zoetis Oral Veterinary Pain Management Drugs Product Portfolio Table 44. Zoetis Recent Development Table 45. Merck & Co Company Information Table 46. Merck & Co Business Overview Table 47. Merck & Co Oral Veterinary Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Merck & Co Oral Veterinary Pain Management Drugs Product Portfolio Table 49. Merck & Co Recent Development Table 50. Medtronic Company Information Table 51. Medtronic Business Overview Table 52. Medtronic Oral Veterinary Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Medtronic Oral Veterinary Pain Management Drugs Product Portfolio Table 54. Medtronic Recent Development Table 55. Lilly Company Information Table 56. Lilly Business Overview Table 57. Lilly Oral Veterinary Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Lilly Oral Veterinary Pain Management Drugs Product Portfolio Table 59. Lilly Recent Development Table 60. Bayer Pharma AG Company Information Table 61. Bayer Pharma AG Business Overview Table 62. Bayer Pharma AG Oral Veterinary Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Bayer Pharma AG Oral Veterinary Pain Management Drugs Product Portfolio Table 64. Bayer Pharma AG Recent Development Table 65. Baxter Company Information Table 66. Baxter Business Overview Table 67. Baxter Oral Veterinary Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Baxter Oral Veterinary Pain Management Drugs Product Portfolio Table 69. Baxter Recent Development Table 70. Norbrook Laboratories Company Information Table 71. Norbrook Laboratories Business Overview Table 72. Norbrook Laboratories Oral Veterinary Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Norbrook Laboratories Oral Veterinary Pain Management Drugs Product Portfolio Table 74. Norbrook Laboratories Recent Development Table 75. Halyard Company Information Table 76. Halyard Business Overview Table 77. Halyard Oral Veterinary Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Halyard Oral Veterinary Pain Management Drugs Product Portfolio Table 79. Halyard Recent Development Table 80. Forest Laboratories Company Information Table 81. Forest Laboratories Business Overview Table 82. Forest Laboratories Oral Veterinary Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Forest Laboratories Oral Veterinary Pain Management Drugs Product Portfolio Table 84. Forest Laboratories Recent Development Table 85. Endo International Company Information Table 86. Endo International Business Overview Table 87. Endo International Oral Veterinary Pain Management Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Endo International Oral Veterinary Pain Management Drugs Product Portfolio Table 89. Endo International Recent Development Table 90. Elanco Company Information Table 91. Elanco Business Overview Table 92. Elanco Oral Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Elanco Oral Veterinary Pain Management Drugs Product Portfolio Table 94. Elanco Recent Development Table 95. Ceva Sante Animale Company Information Table 96. Ceva Sante Animale Business Overview Table 97. Ceva Sante Animale Oral Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Ceva Sante Animale Oral Veterinary Pain Management Drugs Product Portfolio Table 99. Ceva Sante Animale Recent Development Table 100. Bostonscientific Company Information Table 101. Bostonscientific Business Overview Table 102. Bostonscientific Oral Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Bostonscientific Oral Veterinary Pain Management Drugs Product Portfolio Table 104. Bostonscientific Recent Development Table 105. Boehringer Ingelheim Company Information Table 106. Boehringer Ingelheim Business Overview Table 107. Boehringer Ingelheim Oral Veterinary Pain Management Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Boehringer Ingelheim Oral Veterinary Pain Management Drugs Product Portfolio Table 109. Boehringer Ingelheim Recent Development Table 110. North America Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 111. North America Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 112. North America Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Oral Veterinary Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Oral Veterinary Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Oral Veterinary Pain Management Drugs Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe Oral Veterinary Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Oral Veterinary Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe Oral Veterinary Pain Management Drugs Revenue by Country (US$ Million) & (2027-2032) Table 124. China Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 125. China Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 126. China Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 127. China Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Oral Veterinary Pain Management Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Oral Veterinary Pain Management Drugs Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia Oral Veterinary Pain Management Drugs Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA Oral Veterinary Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA Oral Veterinary Pain Management Drugs Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA Oral Veterinary Pain Management Drugs Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Oral Veterinary Pain Management Drugs Image Figure 2. Global Oral Veterinary Pain Management Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Veterinary Pain Management Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sedatives Image Figure 5. Local Anesthetics Image Figure 6. Nonsteroidal Anti-Inflammatory Drugs (NSIDs) Image Figure 7. Opioids Image Figure 8. α2-Adrenergic Agonists Image Figure 9. Other Image Figure 10. Global Oral Veterinary Pain Management Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Oral Veterinary Pain Management Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 12. Veterinary Clinics Image Figure 13. Veterinary Hospitals Image Figure 14. For Retail Image Figure 15. Others Image Figure 16. Global Oral Veterinary Pain Management Drugs Market Size (US$ Million) & (2021-2032) Figure 17. Global Oral Veterinary Pain Management Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Oral Veterinary Pain Management Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Oral Veterinary Pain Management Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Oral Veterinary Pain Management Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Oral Veterinary Pain Management Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Oral Veterinary Pain Management Drugs Revenue Market Share by Type (2021-2032) Figure 24. Global Oral Veterinary Pain Management Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Oral Veterinary Pain Management Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Oral Veterinary Pain Management Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Oral Veterinary Pain Management Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Oral Veterinary Pain Management Drugs Revenue Share by Type (2021-2032) Figure 29. North America Oral Veterinary Pain Management Drugs Revenue Share by Application (2021-2032) Figure 30. North America Oral Veterinary Pain Management Drugs Revenue Share by Country (2021-2032) Figure 31. United States Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Oral Veterinary Pain Management Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Oral Veterinary Pain Management Drugs Revenue Share by Type (2021-2032) Figure 36. Europe Oral Veterinary Pain Management Drugs Revenue Share by Application (2021-2032) Figure 37. Europe Oral Veterinary Pain Management Drugs Revenue Share by Country (2021-2032) Figure 38. Germany Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Oral Veterinary Pain Management Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Oral Veterinary Pain Management Drugs Revenue Share by Type (2021-2032) Figure 48. China Oral Veterinary Pain Management Drugs Revenue Share by Application (2021-2032) Figure 49. Asia Oral Veterinary Pain Management Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Oral Veterinary Pain Management Drugs Revenue Share by Type (2021-2032) Figure 51. Asia Oral Veterinary Pain Management Drugs Revenue Share by Application (2021-2032) Figure 52. Asia Oral Veterinary Pain Management Drugs Revenue Share by Region (2021-2032) Figure 53. Japan Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Oral Veterinary Pain Management Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Oral Veterinary Pain Management Drugs Revenue Share by Type (2021-2032) Figure 61. SAMEA Oral Veterinary Pain Management Drugs Revenue Share by Application (2021-2032) Figure 62. SAMEA Oral Veterinary Pain Management Drugs Revenue Share by Country (2021-2032) Figure 63. Brazil Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Oral Veterinary Pain Management Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Sedatives
  • Local Anesthetics
  • Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
  • Opioids
  • α2-Adrenergic Agonists
  • Other
Applications
  • Veterinary Clinics
  • Veterinary Hospitals
  • For Retail
  • Others
Companies covered
  • Zoetis
  • Merck & Co
  • Medtronic
  • Lilly
  • Bayer Pharma AG
  • Baxter
  • Norbrook Laboratories
  • Halyard
  • Forest Laboratories
  • Endo International
  • Elanco
  • Ceva Sante Animale
  • Bostonscientific
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oral Veterinary Pain Management Drugs Market by Type
  3. 1.2.1 Global Oral Veterinary Pain Management Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sedatives
  5. 1.2.3 Local Anesthetics
  6. 1.2.4 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
  7. 1.2.5 Opioids
  8. 1.2.6 α2-Adrenergic Agonists
  9. 1.2.7 Other
  10. 1.3 Oral Veterinary Pain Management Drugs Market by Application
  11. 1.3.1 Global Oral Veterinary Pain Management Drugs Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Veterinary Clinics
  13. 1.3.3 Veterinary Hospitals
  14. 1.3.4 For Retail
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Oral Veterinary Pain Management Drugs Market Dynamics
  1. 2.1 Oral Veterinary Pain Management Drugs Industry Trends
  2. 2.2 Oral Veterinary Pain Management Drugs Industry Drivers
  3. 2.3 Oral Veterinary Pain Management Drugs Industry Opportunities and Challenges
  4. 2.4 Oral Veterinary Pain Management Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Oral Veterinary Pain Management Drugs Market Perspective (2021-2032)
  2. 3.2 Global Oral Veterinary Pain Management Drugs Growth Trends by Region
  3. 3.2.1 Global Oral Veterinary Pain Management Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oral Veterinary Pain Management Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Oral Veterinary Pain Management Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Oral Veterinary Pain Management Drugs Revenue by Players
  2. 4.1.1 Global Oral Veterinary Pain Management Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Oral Veterinary Pain Management Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Oral Veterinary Pain Management Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oral Veterinary Pain Management Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Oral Veterinary Pain Management Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Oral Veterinary Pain Management Drugs Players, Product Type & Application
  8. 4.5 Global Oral Veterinary Pain Management Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Oral Veterinary Pain Management Drugs Market CR5 and HHI
  11. 4.6.3 2025 Oral Veterinary Pain Management Drugs Tier 1, Tier 2, and Tier 3
5 Oral Veterinary Pain Management Drugs Market Size by Type
  1. 5.1 Global Oral Veterinary Pain Management Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Oral Veterinary Pain Management Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Oral Veterinary Pain Management Drugs Revenue Market Share by Type (2021-2032)
6 Oral Veterinary Pain Management Drugs Market Size by Application
  1. 6.1 Global Oral Veterinary Pain Management Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Oral Veterinary Pain Management Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Oral Veterinary Pain Management Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Oral Veterinary Pain Management Drugs Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Merck & Co
  8. 7.2.1 Merck & Co Company Information
  9. 7.2.2 Merck & Co Business Overview
  10. 7.2.3 Merck & Co Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co Oral Veterinary Pain Management Drugs Product Portfolio
  12. 7.2.5 Merck & Co Recent Developments
  13. 7.3 Medtronic
  14. 7.3.1 Medtronic Company Information
  15. 7.3.2 Medtronic Business Overview
  16. 7.3.3 Medtronic Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Medtronic Oral Veterinary Pain Management Drugs Product Portfolio
  18. 7.3.5 Medtronic Recent Developments
  19. 7.4 Lilly
  20. 7.4.1 Lilly Company Information
  21. 7.4.2 Lilly Business Overview
  22. 7.4.3 Lilly Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Lilly Oral Veterinary Pain Management Drugs Product Portfolio
  24. 7.4.5 Lilly Recent Developments
  25. 7.5 Bayer Pharma AG
  26. 7.5.1 Bayer Pharma AG Company Information
  27. 7.5.2 Bayer Pharma AG Business Overview
  28. 7.5.3 Bayer Pharma AG Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bayer Pharma AG Oral Veterinary Pain Management Drugs Product Portfolio
  30. 7.5.5 Bayer Pharma AG Recent Developments
  31. 7.6 Baxter
  32. 7.6.1 Baxter Company Information
  33. 7.6.2 Baxter Business Overview
  34. 7.6.3 Baxter Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Baxter Oral Veterinary Pain Management Drugs Product Portfolio
  36. 7.6.5 Baxter Recent Developments
  37. 7.7 Norbrook Laboratories
  38. 7.7.1 Norbrook Laboratories Company Information
  39. 7.7.2 Norbrook Laboratories Business Overview
  40. 7.7.3 Norbrook Laboratories Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Norbrook Laboratories Oral Veterinary Pain Management Drugs Product Portfolio
  42. 7.7.5 Norbrook Laboratories Recent Developments
  43. 7.8 Halyard
  44. 7.8.1 Halyard Company Information
  45. 7.8.2 Halyard Business Overview
  46. 7.8.3 Halyard Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Halyard Oral Veterinary Pain Management Drugs Product Portfolio
  48. 7.8.5 Halyard Recent Developments
  49. 7.9 Forest Laboratories
  50. 7.9.1 Forest Laboratories Company Information
  51. 7.9.2 Forest Laboratories Business Overview
  52. 7.9.3 Forest Laboratories Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Forest Laboratories Oral Veterinary Pain Management Drugs Product Portfolio
  54. 7.9.5 Forest Laboratories Recent Developments
  55. 7.10 Endo International
  56. 7.10.1 Endo International Company Information
  57. 7.10.2 Endo International Business Overview
  58. 7.10.3 Endo International Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Endo International Oral Veterinary Pain Management Drugs Product Portfolio
  60. 7.10.5 Endo International Recent Developments
  61. 7.11 Elanco
  62. 7.11.1 Elanco Company Information
  63. 7.11.2 Elanco Business Overview
  64. 7.11.3 Elanco Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Elanco Oral Veterinary Pain Management Drugs Product Portfolio
  66. 7.11.5 Elanco Recent Developments
  67. 7.12 Ceva Sante Animale
  68. 7.12.1 Ceva Sante Animale Company Information
  69. 7.12.2 Ceva Sante Animale Business Overview
  70. 7.12.3 Ceva Sante Animale Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Ceva Sante Animale Oral Veterinary Pain Management Drugs Product Portfolio
  72. 7.12.5 Ceva Sante Animale Recent Developments
  73. 7.13 Bostonscientific
  74. 7.13.1 Bostonscientific Company Information
  75. 7.13.2 Bostonscientific Business Overview
  76. 7.13.3 Bostonscientific Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Bostonscientific Oral Veterinary Pain Management Drugs Product Portfolio
  78. 7.13.5 Bostonscientific Recent Developments
  79. 7.14 Boehringer Ingelheim
  80. 7.14.1 Boehringer Ingelheim Company Information
  81. 7.14.2 Boehringer Ingelheim Business Overview
  82. 7.14.3 Boehringer Ingelheim Oral Veterinary Pain Management Drugs Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Boehringer Ingelheim Oral Veterinary Pain Management Drugs Product Portfolio
  84. 7.14.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Oral Veterinary Pain Management Drugs Revenue (2021-2032)
  2. 8.2 North America Oral Veterinary Pain Management Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Oral Veterinary Pain Management Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Oral Veterinary Pain Management Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Oral Veterinary Pain Management Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Oral Veterinary Pain Management Drugs Revenue by Country
  11. 8.6.1 North America Oral Veterinary Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Oral Veterinary Pain Management Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Oral Veterinary Pain Management Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Oral Veterinary Pain Management Drugs Revenue (2021-2032)
  2. 9.2 Europe Oral Veterinary Pain Management Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Oral Veterinary Pain Management Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Oral Veterinary Pain Management Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Oral Veterinary Pain Management Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Oral Veterinary Pain Management Drugs Revenue by Country
  11. 9.6.1 Europe Oral Veterinary Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Oral Veterinary Pain Management Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Oral Veterinary Pain Management Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Oral Veterinary Pain Management Drugs Revenue (2021-2032)
  2. 10.2 China Oral Veterinary Pain Management Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032)
  5. 10.3 China Oral Veterinary Pain Management Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Oral Veterinary Pain Management Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032)
  9. 10.5 China Oral Veterinary Pain Management Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oral Veterinary Pain Management Drugs Revenue (2021-2032)
  2. 11.2 Asia Oral Veterinary Pain Management Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Oral Veterinary Pain Management Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Oral Veterinary Pain Management Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Oral Veterinary Pain Management Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Oral Veterinary Pain Management Drugs Revenue by Country
  11. 11.6.1 Asia Oral Veterinary Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Oral Veterinary Pain Management Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Oral Veterinary Pain Management Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oral Veterinary Pain Management Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Oral Veterinary Pain Management Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Oral Veterinary Pain Management Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Oral Veterinary Pain Management Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Oral Veterinary Pain Management Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Oral Veterinary Pain Management Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Oral Veterinary Pain Management Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Oral Veterinary Pain Management Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Oral Veterinary Pain Management Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Oral Veterinary Pain Management Drugs Revenue by Country
  11. 12.6.1 SAMEA Oral Veterinary Pain Management Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Oral Veterinary Pain Management Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Oral Veterinary Pain Management Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst